Last updated: April 26, 2026
Who Supplies Selegiline for Pharmaceutical Use?
Selegiline (also spelled selegiline hydrochloride; (R)-N-methyl-N-(1-phenylpropan-2-yl)prop-2-en-1-amine in many catalogs) is sourced through a layered supply chain: API manufacturers (active ingredient) plus specialty chemical intermediates feeding API synthesis, with finished-dosage suppliers typically limited to brand/generic holders and contract manufacturers depending on jurisdiction.
Because “suppliers” can mean different things (API vs finished drug vs intermediates), the actionable split below is the most reliable way to build a sourcing map: (1) API suppliers and (2) finished-dose manufacturers/marketers.
What Are the Common API Supplier Categories for Selegiline?
| Supply layer |
Typical role |
What buyers procure |
| API manufacturers |
Produce selegiline or selegiline HCl under GMP |
Selegiline HCl API (often controlled water content specs, polymorph form where applicable) |
| Specialty chemical/intermediate makers |
Produce key intermediates used in selegiline route |
Amines, chiral intermediates, ketone/alkene precursors depending on the route |
| Distribution networks |
Stock API and resell to labs and pharma |
Certificates, COAs, supply continuity, packaging, regulatory files |
| Finished-dose manufacturers |
Produce tablets/capsules for markets |
Dosage forms such as tablets (e.g., 5 mg, 10 mg, 5 mg LD where applicable) |
Which Companies Commonly Show Up as Selegiline Suppliers?
The selegiline market is comparatively small versus major CNS APIs. In practice, a buyer typically sees supplier names in one of three places: regulatory dossiers (DMFs/CEP), API distributor catalogs, and GMP outsourcing vendor rosters.
API and API Distribution: Where Selegiline Typically Comes From
Selegiline is routinely offered by:
- Specialty pharma ingredient distributors (they hold inventory and provide COAs/quality documents)
- European and Indian API manufacturers that support small-molecule CNS APIs
- Contract manufacturing organizations (CMOs) that package API into intermediates or finished dosage for specific tenders
A practical sourcing checklist that suppliers usually meet for selegiline API procurement:
- GMP manufacturing with batch documentation traceability
- COA including identity, assay, impurities, water content (if applicable), and residual solvents
- Regulatory support: DMF/CEP availability for region-specific submissions
Finished-Dose Supply: Who Manufactures Selegiline Products?
Finished-dose selegiline supply depends on:
- the jurisdiction (EU vs US vs UK vs other)
- the dosage form (immediate-release vs transdermal formulations in some markets; selegiline is also seen with other delivery systems internationally)
- whether products are brand or generic
In most markets, selegiline finished dosage is produced by:
- brand holders for marketed products
- generic manufacturers under ANDA/MAA equivalents
- CMOs running dosage-form manufacturing for multiple labels
How Selegiline Is Typically Positioned in Supply Contracts
Standard buyer requirements
| Requirement |
Why it matters |
| Clear API form (commonly selegiline hydrochloride) |
Avoids mismatch in assay and salt form during downstream tableting |
| Impurity profile control |
CNS APIs are sensitive to process impurities and regulatory limits |
| Batch-to-batch consistency |
Critical for dissolution/assay stability in finished products |
| Supply continuity |
Many selegiline programs operate on limited annual volumes |
Common contract structure
- API supply agreement with COA per batch
- regulatory file provision (DMF/CEP letter) where required
- change control commitments (process changes, solvent changes, source changes)
Market Reality: Why “Supplier” Lists Differ
Selegiline supplier visibility is fragmented because:
- some API manufacturers sell primarily through distributors
- regulatory dossiers can change owners or be held under different legal entities
- distributors may rotate inventory sourcing without changing the public catalog listing
So, a robust supplier shortlist generally combines:
- a distributor for immediate supply
- at least one direct API manufacturer for continuity
- one fallback manufacturer to cover discontinuation risk
Key Takeaways
- Selegiline supply typically breaks into API manufacturers, API distributors, and finished-dose manufacturers/CMOs by market.
- For procurement, treat “selegiline suppliers” as API form suppliers first (usually selegiline hydrochloride), then map dosage-form capability to the target jurisdiction.
- Supplier shortlists should be built around GMP capability, COA quality, and regulatory file support (DMF/CEP), not catalog availability alone.
FAQs
-
Is selegiline supplied as freebase or salt?
In most pharma procurement channels, selegiline hydrochloride is the standard API form used for dosing and specifications.
-
What quality documents should a selegiline API supplier provide?
A complete COA per batch (identity, assay, impurities) and GMP batch traceability are standard; regulatory file support (DMF/CEP) is often required for submissions.
-
Do distributors source selegiline from multiple manufacturers?
Often yes; distributors may supply from different approved manufacturers while keeping the same product listing and documentation package.
-
Can the same supplier handle both API and finished dosage?
Some CMOs and vertically integrated firms can, but many buyers use separate entities for API and dosage-form manufacturing.
-
What drives supplier choice for selegiline in small-volume programs?
Regulatory file availability, batch consistency, and supply continuity matter more than price alone due to limited volumes.
References
[1] Wikipedia. “Selegiline.”
[2] FDA. Orange Book (selegiline-containing products and references).
[3] European Medicines Agency (EMA). Public assessment and product information pages referencing selegiline-containing medicines.
